Results 91 to 100 of about 44,621 (163)

A Pancreatic Cancer Patient-Derived Xenograft Model for Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes. [PDF]

Gastro Hep Adv, 2022
Leone V, Peschke K, Reichert M.
europepmc   +1 more source

Can Adoptive Immunotherapy With Hepatitis E Virus (HEV)-Specific T Cells Address the Unmet Need in Refractory Chronic HEV Infection? [PDF]

Open Forum Infect Dis
Lampejo T.
europepmc   +1 more source

Optimization of Culture Conditions for the Generation of Canine CD20-CAR-T Cells for Adoptive Immunotherapy. [PDF]

In Vivo, 2022
Sakai O, Yamamoto H, Igase M, Mizuno T.
europepmc   +1 more source

Bioceramics Enhance the Anti-Tumor Activity of Immune Cells in Adoptive Immunotherapy. [PDF]

Int J Mol Sci
Nose M, Nitta A, Zheng Y, Kizukuri R, Nagao Y, Nagai S, Aizawa M.   +6 more
europepmc   +1 more source

Adoptive Immunotherapy beyond CAR T-Cells. [PDF]

Cancers (Basel), 2021
Titov A, Zmievskaya E, Ganeeva I, Valiullina A, Petukhov A, Rakhmatullina A, Miftakhova R, Fainshtein M, Rizvanov A, Bulatov E.   +9 more
europepmc   +1 more source

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years. [PDF]

Nat Commun
Neller MA, Ambalathingal GR, Hamad N, Sasadeusz J, Pearson R, Holmes-Liew CL, Singhal D, Tunbridge M, Ng WY, Sharplin K, Moore A, Deambrosis D, Soosay-Raj T, McNaughton P, Whyte M, Fraser C, Grigg A, Kliman D, Bajel A, Cummins K, Dowling M, Yeoh ZH, Harrison SJ, Khot A, Tan S, Roos I, Koo RM, Dohrmann S, Ritchie D, Wainstein B, McCleary K, Nelson A, Gardiner B, Inam S, Badoux X, Ma K, Toro C, Hanna D, Hughes D, Conyers R, Cole T, Wang SS, Chee L, Fleming J, Irish A, Purtill D, Cooney J, Shaw P, Tey SK, Hunt S, Subramonia Pillai E, John G, Ng M, Ramachandran S, Hopkins P, Chambers D, Campbell S, Francis R, Isbel N, Marlton P, Reddiex H, Matthews KK, Voogt M, Panikkar A, Beagley L, Rehan S, Best S, Raju J, Le Texier L, Crooks P, Solomon M, Lekieffre L, Srihari S, Smith C, Khanna R.   +74 more
europepmc   +1 more source

Erratum: Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study. [PDF]

Mol Clin Oncol, 2022
Yamaguchi Y, Katata Y, Sano F, Tanioka H, Okawaki M, Yamamura M, Nagasaka T.   +6 more
europepmc   +1 more source

Engineering safe anti-CD19-CD28ζ CAR T cells with CD8a hinge domain in serum-free media for adoptive immunotherapy. [PDF]

Front Immunol
Muthuvel M, Ganapathy T, Spencer T, Raikar SS, Thangavel S, Srivastava A, Martin S.   +6 more
europepmc   +1 more source

Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8⁺ antigen-specific T cells for adoptive immunotherapy. [PDF]

Mol Ther Methods Clin Dev, 2022
Lak S, Janelle V, Djedid A, Boudreau G, Brasey A, Lisi V, Smaani A, Carli C, Busque L, Lavallée VP, Delisle JS.   +10 more
europepmc   +1 more source

The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer. [PDF]

Cells, 2021
Beumer-Chuwonpad A, Taggenbrock RLRE, Ngo TA, van Gisbergen KPJM.   +3 more
europepmc   +1 more source